NEW YORK , Oct 26: Johnson & Johnson’s first batches of its Covid-19 vaccine could be available for emergency use as soon as January, Ruxandra Draghia-Akli, the company’s head of public health research and development, said in a presentation at the World Health Summit.
The 60,000-person study is expected to have initial results by the end of the year.
|